HKU COVID-19 vaccine trials to start in July
Share - WeChat

A COVID-19 vaccine developed by the University of Hong Kong is expected to begin human trials in July, according to He Yiwu, who leads the HKU vaccine team. However, he told China Daily on Monday that border control could slow down the vaccine manufacturing process as the city must rely on mainland manufacturers. He called for a green channel to facilitate mainland-Hong Kong collaboration in vaccine development.
- 8 held after children found with abnormal blood lead levels
- Country's high-speed rail network wins intl praise
- Thousands of PLA personnel deployed to flood-hit Rongjiang
- China's largest weapons manufacturer appoints new chairman
- Greater Bay Area rail passenger flows surge
- Shanghai exhibit hails role of Flying Tigers in liberating China